Figure 3.
Effect of orally administered GCWB1176 on NK cell activity and ConA-induced T cell proliferation in CTX-immunosuppressed mice. Cyclophosphamide-induced immunosuppressive ICR mice were treated with GCWB1176 (1 × 107 or 1 × 109 cfu/day) for 16 days, and the effects of GCWB1176 on NK cell activity (A) and ConA-induced T cell proliferation (B) were detected. Data are expressed as mean ± SD (n = 8). # p < 0.001 vs. normal group. * p < 0.001 vs. CTX treated group.